CLEVELAND, June 27, 2016 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that it has been added to the Russell 3000®, Russell Global®, and Russell Microcap® Indexes. The addition to the indexes occurred at the close of trading on June 24, 2016 when FTSE Russell reconstituted its comprehensive set of U.S. and global indexes. Indexes provided by FTSE Russell, a leading global index provider, are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies.
"We are honored to be added to the Russell 3000®, Russell Global® and Russell Microcap Indexes," said Chris A. Raanes, ViewRay's president and chief executive officer. "We are at an exciting stage in our Company's development as we advance our MRIdian® linac technology towards commercialization and continue to drive clinical adoption of MRI-guided radiation therapy. The addition to the Russell indexes is a positive reflection of our progress since becoming a public company and will help expand awareness of the ViewRay investment opportunity."
FTSE Russell determines membership for its Russell indexes annually based on objective, market-capitalization rankings and style attributes.
About FTSE Russell
FTSE Russell is a global index leader that provides innovative benchmarking, analytics and data solutions for investors worldwide. FTSE Russell calculates thousands of indexes that measure and benchmark markets and asset classes in more than 70 countries, covering 98% of the investable market globally.
FTSE Russell index expertise and products are used extensively by institutional and retail investors globally. Approximately $10 trillion is currently benchmarked to FTSE Russell indexes. For over 30 years, leading asset owners, asset managers, ETF providers and investment banks have chosen FTSE Russell indexes to benchmark their investment performance and create ETFs, structured products and index-based derivatives.
A core set of universal principles guides FTSE Russell index design and management: a transparent rules-based methodology is informed by independent committees of leading market participants. FTSE Russell is focused on applying the highest industry standards in index design and governance, and embraces the IOSCO principles. FTSE Russell is also focused on index innovation and client collaboration as it seeks to enhance the breadth, depth and reach of its offering.
FTSE Russell is wholly owned by London Stock Exchange Group. For more information, visit www.ftserussell.com.
ViewRay®, Inc. (Nasdaq: VRAY) designs, manufactures and markets the MRIdian radiation therapy system. MRIdian integrates MRI technology, radiation delivery and proprietary software to locate, target and track the position and shape of soft-tissue tumors during radiation. ViewRay believes this combination of enhanced visualization and accuracy will significantly improve outcomes for patients.
ViewRay and MRIdian are registered trademarks of ViewRay, Inc.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/viewray-added-to-russell-3000-russell-global-and-russell-microcap-indexes-300290348.html
SOURCE ViewRay, Inc.